• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硝苯地平对原发性高血压患者的急性和长期降压作用及血浆浓度

Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension.

作者信息

Aoki K, Sato K, Kawaguchi Y, Yamamoto M

出版信息

Eur J Clin Pharmacol. 1982;23(3):197-201. doi: 10.1007/BF00547553.

DOI:10.1007/BF00547553
PMID:7173292
Abstract

The acute and long-term hypotensive effects of low doses of nifedipine, and the correlation between the fall in the blood pressure (BP) and the plasma nifedipine concentration, were investigated in patients with essential hypertension. The oral administration of nifedipine 5 mg rapidly decreased BP from 163 +/- 22/101 +/- 10 to 127 +/- 12/82 +/- 9 mmHg (mean +/- SD; p less than 0.001), and increased heart rate from 72 +/- 8 to 76 +/- 6 beats/min (p less than 0.05), plasma renin activity rose from 1.2 +/- 0.6 to 1.4 +/- 0.8 ng/ml/h (p less than 0.05), and plasma nifedipine concentration was 75.6 +/- 22.0 ng/ml 30 min after administration (n = 7). The nifedipine concentration was significantly correlated both with the fall in BP (r = 0.410, p less than 0.02, n = 31) and the rise in the heart rate (r = 0.412, p less than 0.02, n = 31). Treatment with nifedipine 5 mg t.d.s. alone or in combination either with propranolol 10 mg t.d.s., or thiazide 1 tablet daily, or propranolol and thiazide, controlled BP in 36 patients during the 22 week study period. During the long-term nifedipine therapy, the plasma nifedipine level was significantly correlated with the fall in systolic (r = 0.577, p less than 0.01, n = 20) and diastolic (r = 0.595, p less than 0.01, n = 20) BP. It was concluded that the plasma nifedipine concentration could be correlated with the fall in BP, and that low doses of nifedipine, either as monotherapy or in combination, were effective in the acute and long-term treatment of patients with essential hypertension.

摘要

在原发性高血压患者中,研究了小剂量硝苯地平的急性和长期降压作用,以及血压下降与血浆硝苯地平浓度之间的相关性。口服5毫克硝苯地平后,血压迅速从163±22/101±10毫米汞柱降至127±12/82±9毫米汞柱(平均值±标准差;p<0.001),心率从72±8次/分钟增至76±6次/分钟(p<0.05),血浆肾素活性从1.2±0.6增至1.4±0.8纳克/毫升/小时(p<0.05),给药30分钟后血浆硝苯地平浓度为75.6±22.0纳克/毫升(n=7)。硝苯地平浓度与血压下降(r=0.410,p<0.02,n=31)和心率升高(r=0.412,p<0.02,n=31)均显著相关。在为期22周的研究期间,单独使用5毫克硝苯地平每日三次,或与10毫克普萘洛尔每日三次、或噻嗪类每日一片、或普萘洛尔和噻嗪类联合使用,可使36例患者的血压得到控制。在长期硝苯地平治疗期间,血浆硝苯地平水平与收缩压下降(r=0.577,p<0.01,n=20)和舒张压下降(r=0.595,p<0.01,n=20)显著相关。得出的结论是,血浆硝苯地平浓度与血压下降相关,小剂量硝苯地平无论是单一疗法还是联合使用,对原发性高血压患者的急性和长期治疗均有效。

相似文献

1
Acute and long-term hypotensive effects and plasma concentrations of nifedipine in patients with essential hypertension.硝苯地平对原发性高血压患者的急性和长期降压作用及血浆浓度
Eur J Clin Pharmacol. 1982;23(3):197-201. doi: 10.1007/BF00547553.
2
Acute hypotensive, hemodynamic effects of long-term treatment with niludipine, a Ca2+-antagonist, in patients with essential hypertension. Niludipine monotherapy and combination with a beta-blocker and a diuretic).钙拮抗剂尼鲁地平长期治疗原发性高血压患者的急性降压及血流动力学效应。尼鲁地平单药治疗以及与β受体阻滞剂和利尿剂联合治疗。
Arzneimittelforschung. 1982;32(9):1141-5.
3
Hypotensive action and increased plasma renin activity by Ca2+ antagonist (Nifedipine) in hypertensive patients.钙离子拮抗剂(硝苯地平)对高血压患者的降压作用及血浆肾素活性的影响
Jpn Heart J. 1976 Jul;17(4):479-84. doi: 10.1536/ihj.17.479.
4
Hypotensive action of nifedipine (Ca2+-antagonist) and propranolol in acute trials and its long-term therapy of hypertensive coronary heart disease patients.硝苯地平(钙拮抗剂)和普萘洛尔在急性试验中的降压作用及其对高血压冠心病患者的长期治疗
Jpn Heart J. 1981 Jul;22(4):575-84. doi: 10.1536/ihj.22.575.
5
Management of severe hypertension with nifedipine in combination with clonidine or propranolol.硝苯地平联合可乐定或普萘洛尔治疗重度高血压
Arzneimittelforschung. 1980;30(4):674-8.
6
Effect of nifedipine on plasma renin, aldosterone and catecholamines in arterial hypertension.硝苯地平对动脉高血压患者血浆肾素、醛固酮和儿茶酚胺的影响。
Eur J Clin Pharmacol. 1979 May 21;15(4):235-40. doi: 10.1007/BF00618511.
7
Plasma renin activity and norepinephrine as predictors for antihypertensive effects of nifedipine and captopril.血浆肾素活性和去甲肾上腺素作为硝苯地平和卡托普利降压效果的预测指标。
Am J Hypertens. 1991 Sep;4(9):735-9. doi: 10.1093/ajh/4.9.735.
8
Rectal administration of nifedipine: haemodynamic effects and pharmacokinetics in hypertensives.硝苯地平直肠给药:高血压患者的血流动力学效应和药代动力学
J Int Med Res. 1987 May-Jun;15(3):121-7. doi: 10.1177/030006058701500301.
9
[Acute effect of nifedipine on arterial pressure and the renin-angiotensin system in healthy subjects and hypertensives].硝苯地平对健康受试者和高血压患者动脉血压及肾素-血管紧张素系统的急性影响
Arch Mal Coeur Vaiss. 1985 Nov;78 Spec No:29-32.
10
Acute and long-term treatment of hypertension with nifedipine in the elderly.
J Hum Hypertens. 1990 Aug;4(4):410-4.

引用本文的文献

1
Determination of (+)- and (-)-nicardipine concentrations in human serum and their correlation with the antihypertensive effect after oral administration of racemic nicardipine.口服消旋尼卡地平后人体血清中(+)-和(-)-尼卡地平浓度的测定及其与降压效果的相关性。
Eur J Clin Pharmacol. 1995;48(5):345-9. doi: 10.1007/BF00194949.
2
Plasma nifedipine levels and fall in blood pressure in a 53 year old woman.
Eur J Clin Pharmacol. 1983;25(1):143-4. doi: 10.1007/BF00544032.
3
Hypotensive effects of diltiazem to normals and essential hypertensives.地尔硫䓬对正常人和原发性高血压患者的降压作用。

本文引用的文献

1
Different antihypertensive effects of nifedipine in conscious experimental hypertensive and normotensive rats.硝苯地平对清醒实验性高血压大鼠和正常血压大鼠的不同降压作用。
Eur J Pharmacol. 1980 May 30;64(1):21-9. doi: 10.1016/0014-2999(80)90365-9.
2
Short- and long-term efficacy of a calcium-antagonistic agent (nifedipine) combined with methyldopa in the treatment of severe hypertension.一种钙拮抗剂(硝苯地平)联合甲基多巴治疗重度高血压的短期和长期疗效
Circulation. 1980 May;61(5):913-9. doi: 10.1161/01.cir.61.5.913.
3
Identification of nifedipine metabolites and their determination by gas chromatography.
Eur J Clin Pharmacol. 1983;25(4):475-80. doi: 10.1007/BF00542114.
4
Food and nifedipine pharmacokinetics.食物与硝苯地平的药代动力学
Br J Clin Pharmacol. 1987 Feb;23(2):248-9. doi: 10.1111/j.1365-2125.1987.tb03040.x.
5
The effects of food and posture on the pharmacokinetics of a biphasic release preparation of nifedipine.食物和体位对硝苯地平双相释放制剂药代动力学的影响。
Br J Clin Pharmacol. 1986 Nov;22(5):565-70. doi: 10.1111/j.1365-2125.1986.tb02936.x.
6
Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.硝苯地平。药代动力学与药效学之间的关系。
Clin Pharmacokinet. 1987 Jan;12(1):12-29. doi: 10.2165/00003088-198712010-00002.
7
Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.维拉帕米、硝苯地平和地尔硫䓬的临床药代动力学。
Clin Pharmacokinet. 1986 Nov-Dec;11(6):425-49. doi: 10.2165/00003088-198611060-00002.
8
The management of hypertension.高血压的管理
Br J Clin Pharmacol. 1986;21 Suppl 2(Suppl 2):129S-142S. doi: 10.1111/j.1365-2125.1986.tb02862.x.
9
Drug treatment of hypertension.高血压的药物治疗
Drugs. 1988;35 Suppl 6:40-52. doi: 10.2165/00003495-198800356-00006.
10
The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.硝苯地平、维拉帕米和地尔硫䓬对冠心病患者的血流动力学影响。综述。
Drugs. 1986 Jul;32(1):66-101. doi: 10.2165/00003495-198632010-00004.
Chem Pharm Bull (Tokyo). 1980 Jan;28(1):1-7. doi: 10.1248/cpb.28.1.
4
Hypotensive action of nifedipine (Ca2+-antagonist) and propranolol in acute trials and its long-term therapy of hypertensive coronary heart disease patients.硝苯地平(钙拮抗剂)和普萘洛尔在急性试验中的降压作用及其对高血压冠心病患者的长期治疗
Jpn Heart J. 1981 Jul;22(4):575-84. doi: 10.1536/ihj.22.575.
5
Antihypertensive effect of fractionated sublingual administration of nifedipine in moderate essential hypertension.
Eur J Clin Pharmacol. 1980;17(3):161-4. doi: 10.1007/BF00561894.
6
[Electromechanical uncoupling of vascular smooth muscle as the basic principle of coronary dilatation by 4-(2'-nitrophenyl-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (BAY a 1040, Nifedipine). 1. The significance of Ca ++ ions for the bioelectrical and mechanical activity of smooth muscle].[血管平滑肌的机电解偶联作为4-(2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯(BAY a 1040,硝苯地平)冠脉扩张的基本原理。1. Ca++离子对平滑肌生物电和机械活动的意义]
Arzneimittelforschung. 1972 Feb;22(2):334-44.
7
Vasodilator drugs in the treatment of hypertension.
Arch Intern Med. 1974 Jun;133(6):1017-27.
8
Antihypertensive effect of (4-2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarbonic acid dimethylester (Nifedipine, Bay-a 1040), a new coronary dilator.新型冠脉扩张剂(4-2'-硝基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯(硝苯地平,Bay-a 1040)的降压作用
Jpn Heart J. 1972 Mar;13(2):128-35. doi: 10.1536/ihj.13.128.
9
Treatment of essential hypertension with a new vasodilator in combination with beta-adrenergic blockade.用一种新型血管扩张剂联合β-肾上腺素能阻滞剂治疗原发性高血压。
N Engl J Med. 1970 Mar 5;282(10):521-7. doi: 10.1056/NEJM197003052821001.
10
Control plasma renin activity and changes in sympathetic tone as determinants of minoxidil-induced increase in plasma renin activity.作为米诺地尔诱导血浆肾素活性增加的决定因素,控制血浆肾素活性和交感神经张力的变化。
J Clin Invest. 1975 Feb;55(2):230-5. doi: 10.1172/JCI107926.